Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

How anxiety disorders may be treated with a testosterone nasal spray

Staff Writer
Staff Writer 1 year ago
Updated 2021/05/12 at 6:20 PM
Share
SHARE

Researchers at the University of Texas at Austin, in collaboration with MedCara Pharmaceuticals, licensed the first testosterone nasal spray to alleviate symptoms of anxiety disorders.

With patents in the U.S. and Europe, its use allows for an alternative approach to treat anxiety disorders. Benzodiazepines, as do other sedatives with anxiolytic effects, results in unnecessary side effects. The nasal spray treats symptoms of severe anxiety without sedation.

“With this second U.S. patent and a first European patent supporting these claims, we’re one step closer to introducing a new weapon in the ongoing battle against mental illness,” said one of the study’s authors in a press release.

“A growing body of research points to testosterone’s importance in the etiology of anxiety disorders,” the author also stated.

“We are pleased to have partnered with UT Austin and Professor Josephs for the development of this technology. We expect that this new technology will allow us to develop therapeutic options that will complement our existing nasal technology. Acerus’ expertise in the formulation and development of nasally delivered active pharmaceutical ingredients, and more particularly testosterone, should enable Acerus to make this new technology a success,” states a press release by Acerus Pharmaceuticals Corporation.

A patent in China is in the works, with expectations for the nasal spray to be sold worldwide.

Photo: MedicalNewsToday

You Might Also Like

New research identifies anxious feelings using walking gait, sensors, and machine learning

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

Being overweight during childhood may raise the risk of type 1 diabetes

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

Antidepressant use not associated with better health-related quality of life over time

TAGGED: mental health, testosterone, anxiety disorders
Staff Writer December 30, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New clinical guideline recommendations say multi-component CBT very effective for chronic insomnia
Next Article 50 Biggest News Stories of 2020

Recommended

Clinical

New research identifies anxious feelings using walking gait, sensors, and machine learning

2 Min Read
Health

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

1 Min Read
Health

Being overweight during childhood may raise the risk of type 1 diabetes

1 Min Read
Health

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?